Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
BioSpace8d
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
X4 Pharmaceuticals: Q4 Earnings Snapshot
X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...
Hosted on MSN2mon
Ironwood Pharmaceuticals announces workforce reduction
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) has disclosed a significant workforce reduction plan, aiming to lower operational costs and refocus its business strategy. The Boston-based ...
Yahoo Finance21d
Jazz Pharmaceuticals and Boston Beer Company have been highlighted as Zacks Bull and Bear of the Day
Jazz Pharmaceuticals, a Zacks Rank #1 (Strong Buy), is a specialty biopharmaceutical company that identifies, develops, and commercializes pharmaceutical products in the United States, Europe ...
PharmiWeb1mon
Veranova Relocates Headquarters to Devens, MA
Strategically located near the Boston pharmaceutical and biotech hub, Veranova’s Devens site is an FDA approved facility and a center of excellence for development through clinical and commercial ...
Morningstar1mon
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston
About Verrica Pharmaceuticals Inc. Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s product YCANTH (VP-102 ...